RECORD // Company
Axim Biotechnologies, Inc.
Formerly: AXIM INTERNATIONAL INC.
Built 2026-11-21T18:02:15Z from public sources · JSON · Open the company profile
ASK THE RECORDS
Ask
COMPANY
Records for this company (1 joined by official identifier)
Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.
SEC EDGAR (1)
- AXIM BIOTECHNOLOGIES, INC. · the SEC registrant record of this company
Matched by name only, not merged (3)
These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).
- Axim Biotechnologies · Ctgov · exact name match to 'AXIM BIOTECHNOLOGIES, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
- AXIM BIOTECHNOLOGIES, INC. · Ny corps · same registered legal name as 'AXIM BIOTECHNOLOGIES, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
- AXIM BIOTECHNOLOGIES, INC. · USAspending · same registered legal name as 'AXIM BIOTECHNOLOGIES, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
4 VALUES · 10-Q · EACH LINKS TO ITS FILING
Latest quarter
Latest report: 10-Q for the period ended 2024-06-30, filed 2024-08-19 · accession 0001096906-24-001772
Old data: this filer's newest 10-Q or 10-K in SEC company facts is for the period ended 2024-06-30. No later report has XBRL values.
| Item | Value | Period | Form | Filed | Accession | Report | |
|---|---|---|---|---|---|---|---|
| Revenue | $17,479 | 3 months ended 2024-06-30 | 10-Q | 2024-08-19 | 0001096906-24-001772 | 2026-11-21 18:02 UTC | Report an error |
| Net income (loss) | $-2,269,815 | 3 months ended 2024-06-30 | 10-Q | 2024-08-19 | 0001096906-24-001772 | 2026-11-21 18:02 UTC | Report an error |
| Interest expense | $178,244 | 3 months ended 2024-06-30 | 10-Q | 2024-08-19 | 0001096906-24-001772 | 2026-11-21 18:02 UTC | Report an error |
| Cash and cash equivalents | $6,044 | at 2024-06-30 | 10-Q | 2024-08-19 | 0001096906-24-001772 | 2026-11-21 18:02 UTC | Report an error |
Negative as reported in the filing.
Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.
IDS
Identifiers
- SEC CIK
- 0001514946
- Ticker
- AXIM
- EIN
- 274092986
- CUSIP
- 05463J107
- Record ID
- sx:sec:0001514946
OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA
Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
18 FACTS · EACH LINKS TO ITS FILING
Facts
| Fact | Value | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|
| SEC entity type | operating | 2024-12-06 | SEC EDGAR company profile | 2026-11-21 18:02 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2024-12-06 | SEC EDGAR company profile | 2026-11-21 18:02 UTC | Report an error |
| State of incorporation | NV | 2024-12-06 | SEC EDGAR company profile | 2026-11-21 18:02 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2024-12-06 | SEC EDGAR company profile | 2026-11-21 18:02 UTC | Report an error |
| Business address | 6191 CORNERSTONE COURT, E, SUITE 114, SAN DIEGO, CA, 92121 | 2024-12-06 | SEC EDGAR company profile | 2026-11-21 18:02 UTC | Report an error |
| Exchanges | OTC | 2024-12-06 | SEC EDGAR company profile | 2026-11-21 18:02 UTC | Report an error |
| Revenue (fiscal year ended 2023-12-31) | $39,518 | 2023-12-31 | 10-K, XBRL Revenues | 2026-11-21 18:02 UTC | Report an error |
| Net income (loss) (fiscal year ended 2023-12-31) | $-8,059,682 | 2023-12-31 | 10-K, XBRL NetIncomeLoss | 2026-11-21 18:02 UTC | Report an error |
| Total assets (at 2023-12-31) | $4,121,548 | 2023-12-31 | 10-K, XBRL Assets | 2026-11-21 18:02 UTC | Report an error |
| Stockholders' equity (at 2023-12-31) | $-7,656,647 | 2023-12-31 | 10-K, XBRL StockholdersEquity | 2026-11-21 18:02 UTC | Report an error |
| Cash and cash equivalents (at 2023-12-31) | $156,457 | 2023-12-31 | 10-K, XBRL CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | 2026-11-21 18:02 UTC | Report an error |
| Operating cash flow (fiscal year ended 2023-12-31) | $-1,030,500 | 2023-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | 2026-11-21 18:02 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2023-12-31) | $0 | 2023-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | 2026-11-21 18:02 UTC | Report an error |
| Form D total offering amount (D filed 2020-06-15) | $5,000,000 | 2020-06-15 | D | 2026-11-21 18:02 UTC | Report an error |
| Form D total amount sold (D filed 2020-06-15) | $500,000 | 2020-06-15 | D | 2026-11-21 18:02 UTC | Report an error |
| Form D industry group | Biotechnology | 2020-06-15 | D | 2026-11-21 18:02 UTC | Report an error |
| Form D revenue range | $1 - $1,000,000 | 2020-06-15 | D | 2026-11-21 18:02 UTC | Report an error |
| Form D date of first sale | 2020-06-10 | 2020-06-15 | D | 2026-11-21 18:02 UTC | Report an error |
EVERY DATED RECORD, NEWEST FIRST
Timeline
- 2024-12-06 Filing 15-12G filed (AXIM BIOTECHNOLOGIES, INC. FORM 15-12G)
- 2024-11-13 Filing NT 10-Q filed (AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q)
- 2024-10-15 Filing 8-K filed: Item 5.01 change in control; Item 5.02 officer or director change
- 2024-08-19 Filing 10-Q filed (FORM 10-Q)
- 2024-08-13 Filing NT 10-Q filed (AXIM BIOTECHNOLOGIES FORM 12B-25)
- 2024-05-22 Filing 10-Q/A filed (FORM 10-Q/A)
- 2024-05-20 Filing 10-Q filed (FORM 10-Q)
- 2024-05-15 Filing NT 10-Q filed (AXIM BIOTECHNOLOGIES FORM 12B-25)
- 2024-04-16 Filing 10-K filed (FORM 10-K)
- 2024-04-01 Filing NT 10-K filed (AXIM BIOTECHNOLOGIES, INC. - NT 10K)
- 2024-03-21 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 9.01 exhibits
- 2024-02-13 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale
- 2023-12-28 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 9.01 exhibits
- 2023-11-20 Filing 10-Q filed (FORM 10-Q)
- 2023-11-14 Filing NT 10-Q filed (AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q)
- 2023-09-21 Filing DEF 14C filed (AXIM BIOTECHNOLOGIES, INC. - DEF14C)
- 2023-08-31 Filing PRE 14C filed (SCHEDULE 14C INFORMATION)
- 2023-08-21 Filing 10-Q filed (AXIM BIOTECHNOLOGIES FORM 10-Q)
- 2023-08-14 Filing NT 10-Q filed (AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q)
- 2023-06-09 Filing EFFECT filed
- 2023-06-07 Filing CORRESP filed
- 2023-06-07 Filing UPLOAD filed
- 2023-06-02 Filing S-1 filed (FORM S-1)
- 2023-06-02 Filing 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
- 2023-05-30 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 9.01 exhibits
WHAT IS NOT HERE
Gaps
- Court records: not covered yet (expected 11-19).
- No H-1B LCA filed under EIN 274092986 in FY2026 Q3
- H-1B LCAs only (H-1B1 and E-3 excluded); one fiscal quarter (FY2026 Q3) only, earlier quarters not loaded
- No Form 5500 plan filed under sponsor EIN 274092986 for plan year 2025
- Plan year 2025 only (EFAST2 'Latest' file); earlier years not loaded
- No Form 990 found for EIN 274092986
- SEC 13F holders: no 13F holdings for this CUSIP in period 2026-06-30
- USAspending: no recipient whose SAM legal name and address match this SEC filer
SOURCES AND LICENSE
Sources
- SEC EDGAR: checked · 2026-11-21T18:02:16Z
- DOL OFLC LCA Disclosure Data: checked, nothing found · 2026-11-21T18:02:16Z
- DOL EBSA Form 5500 public datasets: checked, nothing found · 2026-11-21T18:02:16Z
- Propublica 990: checked, nothing found · 2026-11-21T18:02:16Z
- SEC 13F holdings: checked · 2026-11-21T18:02:17Z
- USAspending: checked, nothing found · 2026-11-21T18:02:18Z
CC BY 4.0 -- credit Seraphix Systems.
API
Use this record
Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.